Pub. Date : 2013
PMID : 23714542
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Patients with EGFR mutations or ALK fusions should be treated with erlotinib or crizotinib, respectively, even in patients with tumor-related poor performance. | Erlotinib Hydrochloride | ALK receptor tyrosine kinase | Homo sapiens |